XML Cancer News

Novel regulatory mechanism for cell division found

published about 12 hours ago
(University of Texas M. D. Anderson Cancer Center) A protein kinase or enzyme known as PKM2 has proven to control cell division, potentially providing a molecular basis for tumor diagnosis and treatment.

New model of follow up for breast cancer patients

published about 12 hours ago
(University of Adelaide) Public health researchers from the University of Adelaide have evaluated international breast cancer guidelines, finding that there is potential to improve surveillance of breast cancer survivors from both a patient and health system perspective.

Possibilities for personalized vaccines revealed at ESMO symposium

published about 12 hours ago
(European Society for Medical Oncology) The possibilities for personalized vaccines in all types of cancer are revealed today at the ESMO Symposium on Immuno-Oncology 2014 in Geneva, Switzerland.

Three drugs may be better than one for certain patients with advanced colorectal cancer

published 1 day ago
(ECCO-the European CanCer Organisation) Patients with a form of advanced colorectal cancer that is driven by a mutated version of the BRAF gene have limited treatment options available. However, results, reported at the 26th EORTC-NCI-AACR Symposium, from a multi-center clinical trial suggest that the cancer may respond to a combination of three targeted drugs: encorafenib, cetuximab and alpelisib.

PharmaMar presents results at EORTC-NCI-AACR to highlight a pipeline of targeted therapies

published 1 day ago
(Pharmamar) PharmaMar will present data at the EORTC-NCI-AACR for its drug Yondelis and several investigational compounds, highlighting its pipeline of targeted therapies. Some of the most relevant results showed will focus on the mechanism of action of Aplidin, a drug that is currently in clinical trials for the treatment of multiple myeloma, and the activity of a new antibody-drug conjugate on HER-2 positive tumor cells and xenograft tumors.